Aflibercept in Recurrent or Persistent CNV — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Aflibercept in Recurrent or Persistent CNV — Stella

Home/Age Related Macular Degeneration/

View on ClinicalTrials.gov

Recruiting

Back to Age Related Macular Degeneration trials

Trial locations(1 site)

Austria

Medical University of Vienna, Vienna

Key details

Sponsor

Medical University of Vienna

Enrollment target

~80 participants

Started

December 2015

Primary completion

November 2025

This trial's estimated completion date has passed — the record may not be fully up to date.

Age range

50 Years and older

Last updated November 2024

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.